PTGS2 and migraine disorder: In summary, overexpression of miR‐34a‐5p inhibited the expression of SIRT1 and increased the expression or release of IL‐1β/COX2/PEG2, which further enhanced the release of CGRP, thereby triggering the pain during migraine onset.